2010 |
| BiPar Sciences, Inc. |
Senior Director, Medical Development |
| Inimex Pharmaceuticals, Inc. |
Vice President, Clinical Development |
| Neuraltus Pharmaceuticals |
Vice President, Clinical Development |
2009 |
| Client |
Position |
| Arresto BioSciences |
Vice President, Clinical Development |
| BiPar Sciences |
Vice President, Medical Development |
| BiPar Sciences |
Senior Director, Regulatory Affairs |
| BrainCells, Inc. |
Chief Medical Officer |
| Elan Pharmaceuticals, Inc. |
Director, Clinical Development |
| Exelixis Pharmaceuticals |
Medical Director |
| Hyperion Therapeutics, Inc. |
Global Vice President, Clinical Operations |
| Omeros Corporation |
Vice President, Clinical Development |
| Portola Pharmaceuticals |
Director, Clinial Development |
| Shire Human Genetic Therapies |
Medical Director |
2008 |
| Client |
Position |
| Affymax, Inc. |
Executive Director, Medical Affairs |
| Ambrx, Inc. |
Chief Medical Officer |
| Amicus Therapeutics |
Chief Medical Officer |
| Apieron Inc. |
Vice President, Clinical & Reg. Affairs |
| Avigen, Inc. |
Associate Vice President |
| Cardium |
Vice President & Chief Medical Officer |
| Catalyst Biosciences, Inc. |
Chief Medical Officer |
| Cerexa, Inc. |
Senior Director, Clinical Operations |
| Cerexa, Inc. |
Vice President, Clinical Sciences |
| Cerimon Pharmaceuticals |
Senior Director, Clinical Development |
| Dynavax Technologies |
Executive Vice President & Chief Development Officer |
| Halozyme Therapeutics |
Vice President, Endocrinology |
| NextWave Pharmaceuticals |
Chief Medical Officer |
| Oxigene |
Director/Senior Director, Oncology |
| Oxigene |
Medical Director |
| Point BioMedical Corp. |
Vice President, Clinical Operations |
| Portola Pharmaceuticals |
Director, Clinical Development |
| Sorbent Therapeutics |
Vice President, Clinical & Medical Affairs |
| Theravance, Inc. |
Director, Clinical Pharmacology |
| Theravance, Inc. |
Vice President, Clinical Pharmacology |
| Trubion Pharmaceuticals |
Chief Medical Officer |
| Veracyte, Inc. |
Chief Medical Officer |
| Zosano Pharma |
Vice President, Clinical |
2007 |
| Client |
Position |
| Achaogen, Inc. |
Chief Medical Officer |
| Cell Therapeutics, Inc. |
Medical Director |
| Dynavax Technologies |
Senior Director, Clinical Operations |
| Dynavax Technologies |
Senior Manager, Reg. Affairs |
| Kythera Biopharmaceuticals |
Chief Medical Officer |
| Logical Therapeutics, Inc. |
Vice President, Reg. Affairs |
| Logical Therapeutics, Inc. |
Chief Medical Officer |
| Neurobiological Technology, Inc. |
Vice President, Clinical Programs |
| NephroGenex, Inc. |
Chief Medical Officer |
| SanBio, Inc. |
Vice President, Development & Reg. Affairs |
| Stryker Biotech |
Medical Director |
| Targanta Therapeutics |
Director, Clinical Science |
| Targanta Therapeutics |
Senior Director, Clinical Development |
| Theravance, Inc. |
Associate Director, Clinical Research |
| Theravance, Inc. |
Director, Clinical Research |
| Trubion Pharmaceuticals |
Medical Director |
2006 |
| Client |
Position |
| Alexza Pharmaceuticals, Inc. |
Senior Director, Program Management |
| Allergan, Inc. |
Vice President, Development, Botox & Neurology |
| Allergan, Inc. |
Global Medical Director, Ophthalmology Clinical Research |
| Anthera Pharmaceuticals |
Senior Vice President, Clinical Development
(Pulmonary/Critical Care) |
| ARYx Therapeutics, Inc. |
Clinical Operations Program Manager |
| Cadence Pharmaceuticals, Inc. |
Executive Vice President, Development/Chief Medical Officer |
| Celator Pharmaceuticals, Inc. |
Chief Medical Officer |
| CoTherix, Inc. |
Vice President, Clinical Research |
| Dynavax Technologies |
Senior Director, Clinical Development |
| Dynavax Technologies |
Vice President, Regulatory Affairs |
| Dynavax Technologies |
Vice President, Clinical Development |
| Essentialis, Inc. |
Vice President, Clinical Development |
| InterMune, Inc. |
Director, Clinical Science - Hepatology |
| Kosan Biosciences Inc. |
Vice President, Clinical Development & Chief Medical Officer |
| Kythera Biopharmaceuticals |
Director of Clinical Operations |
| Napo Pharmaceuticals, Inc. |
Vice President, Clinical Affairs & Chief Medical Officer |
| Novalar Pharmaceuticals |
Vice President of Regulatory Affairs and Quality Assurance |
| Omeros Corporation |
Vice President, Clinical Development |
| Omeros Corporation |
Vice President, Regulatory Affairs |
| Tioga Pharmaceuticals, Inc. |
Vice President, Clinical Development |
2005 |
| Client |
Position |
| Affymax, Inc. |
Medical Director |
| Aperon Biosystems |
Head of Clinical Data Management |
| BiPar Sciences Inc. |
Vice President, Clinical Development |
| IBT Reference Labs |
Head of Contract Research & Clinical Trials |
| ICOS Corporation |
Vice President, Development & Chief Medical Officer |
| Incyte Corporation |
Head, Early Drug Development |
| Incyte Corporation |
Vice President, Late Stage Drug Development |
| Intarcia Therapeutics |
Medical Director |
| InterMune, Inc. |
Assoc. Director, Pulmonary |
| KaloBios |
Vice President, Clinical Development |
| Metabasis Therapeutics |
Senior Director, Clinical Operations |
| Metabasis Therapeutics |
Vice President, Regulatory Affairs & Quality Assurance |
| Oncogenex Technologies |
Chief Medical Officer |
| Orexigen Therapeutics, Inc. |
Chief Medical Officer |
| Theravance, Inc. |
Senior Director, Clinical Research |
| TransOral Pharmaceuticals |
Senior Director, Clinical Development |
| Vitae Pharmaceuticals, Inc. |
Chief Medical Officer |
2004 |
| Client |
Position |
| ACCU Therapeutics |
Chief Medical Officer |
| Aerogen |
Senior Director, Clinical Operations |
| Affymax, Inc. |
Director, Clinical Development |
| Affymax, Inc. |
Vice President, Clinical Development |
| Ansata Therapeutics |
Senior Vice President, Development |
| ArYx Pharmaceuticals |
Director, Clinical Operations |
| Callisto Pharmaceuticals |
Vice President, Regulatory Affairs |
| Conforma Therapeutics |
Vice President, Clincial Development & Chief Medical Officer |
| Cytokinetics, Inc. |
Senior Vice President, Clinical Research & Development |
| GlobeImmune |
Chief Medical Officer |
| Incyte Corporation |
Vice President, Oncology Drug Development |
| InterMune, Inc. |
Director, Clinical Science |
| Novalar Pharmaceuticals |
Vice President, Clinical Development |
| OncoGenex Technologies |
Board Member |
2003 |
| Client |
Position |
| Cell Therapeutics, Inc. |
Medical Director I |
| Cotherix, Inc. |
Director, Regulatory Affairs |
| Dynavax Technologies Corp. |
Vice President & Chief Medical Officer |
| InterMune, Inc. |
Senior Director, Safety & Pharmacovigilance |
| Millennium Pharmaceuticals |
Director, Clinical Research |
| Peninsula Pharmaceuticals |
Alliance Manager |
| Peninsula Pharmaceuticals |
Senior Director, Regulatory Affairs |
| Peninsula Pharmaceuticals, Inc. |
Medical Director |
| Peninsula Pharmacueticals |
Associate Director, Regulatory Affairs |
| Saegis Pharmaceuticals, Inc. |
Vice President, Clinical Development |
| Theravance Corporation |
Senior Director, Clinical Pharmacology |
2002 |
| Client |
Position |
| Actelion Pharmaceuticals US, Inc. |
Medical Director |
| Exhale Therapeutics |
Director, Clinical Operations |
| FeRx, Incorporated |
Vice President, Medical Affairs |
| ICOS Corporation |
Director, Clinical Safety |
| InterMune, Inc. |
Vice President, Medical Affairs |
| MedImmune, Inc. |
Senior Director, Medical Affairs |
| Peninsula Pharmaceuticals |
Chief Medical Officer |
| Santarus Inc. |
Director, Clinical Research |
| Santarus Inc. |
Medical Director |
| Theravance, Inc. |
Director, Regulatory Affairs |
| Xcyte Therapies Inc. |
Director, Clinical Operations |
